Breaking news

Additional mRNA vaccination recommended – Johnson & Johnson vaccine offers “insufficient protection”

PublishedOctober 7, 2021, 7:32 pm

The Standing Vaccination Commission (Stiko) in Germany considers vaccination protection for the corona vaccine Janssen from Johnson & Johnson to be insufficient. According to the Stiko recommendation, people who have been vaccinated with the corona vaccine from Johnson & Johnson should also receive an additional dose of an mRNA vaccine – from four weeks after the Janssen immunization, for which only one dose is generally recommended will. The experts justify this, among other things, with the lower effectiveness.

This is justified with the so-called vaccination breakthroughs, i.e. infections with the coronavirus despite a vaccination. Most of these vaccination breakthroughs were recorded in those vaccinated with Johnson & Johnson. Likewise, the effectiveness of the vaccine against the highly contagious Delta variant is comparatively low in contrast to the other corona vaccines. The Stiko speaks of “insufficient vaccination protection”. In the case of the Johnson & Johnson vaccine, one dose was previously considered sufficient for full vaccination protection.

According to the Stiko recommendation, people who have been vaccinated with the corona vaccine from Johnson & Johnson should also receive an additional dose of an mRNA vaccine – from four weeks after the Janssen immunization, for which only one dose is generally recommended will. The experts justify this, among other things, with the lower effectiveness.

20 Minuten reported as early as mid-September that at that time over 6000 people in Germany had been infected with the coronavirus and had a serious illness despite being vaccinated. According to the Robert Koch Institute (RKI), there would be around 2000 vaccination breakthroughs for every million people vaccinated with the Johnson & Johnson preparation. For comparison: For people who received the vaccine most frequently used in Germany – Biontech / Pfizer – as a second dose, these figures show around 675 breakthroughs per million people who were completely vaccinated.

The vaccine from Johnson & Johnson has been approved in Switzerland since March 2021. However, the Janssen vaccine has only been available since Wednesday. The federal government has high hopes for the vaccine because it is also intended to motivate mRNA skeptics to vaccinate. The Janssen vaccine is a vector vaccine. The federal government recommends the vaccine to people who “don’t want an mRNA vaccine”.

In the canton of Aargau, 700 people registered for the vaccination with the vector vaccine by Wednesday morning. You can also register in Schwyz since Wednesday. The canton pharmacist observed a great deal of interest. According to the pivotal study, the Janssen vaccine protects 66% against illness and reduces the severity of the disease by 85%. The vaccine only starts to work after 22 days, and the Covid certificate is only valid from then on.

Do you or does someone you know have problems with the corona time?

As a member, you become part of the 20-minute community and benefit from great benefits and exclusive competitions every day!

 
For Latest Updates Follow us on Google News
 

PREV Verstappen – Hamilton: What Ralf Schumacher wants to see / Formula 1
NEXT Woman found dead in cellar in Vienna-Brigittenau – crime